GlassScriptPhysician profile
German G Lasala
NPI 1124086392
$1,110.62
in general payments reported to CMS, 2019-2025
14 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2021: $16.95 · 2022: $290 · 2023: $267 · 2024: $17.80 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $132.58 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $130.98 | 2019 | |
| Amarin Pharma, INC. | $125.00 | 2019 | |
| Idorsia Pharmaceuticals US INC | $121.83 | 2023 | Quviviq |
| Stryker Corporation | $121.51 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $118.17 | 2022 | |
| Glaxosmithkline, LLC. | $108.74 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $96.43 | 2022 | |
| Lilly USA, LLC | $75.38 | 2022 | |
| Amgen INC. | $19.57 | 2019 | |
| Exact Sciences Corporation | $17.80 | 2024 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $16.95 | 2021 | |
| Astellas Pharma US INC | $13.57 | 2025 | Veozah |
| Itamar Medical INC | $12.11 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw German Lasala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.